Researchers combine drugs to develop new treatment for human parainfluenza virus
Griffith’s Institute for Glycomics have made a promising discovery in the treatment and prevention of human parainfluenza virus.
Griffith’s Institute for Glycomics have made a promising discovery in the treatment and prevention of human parainfluenza virus.
Pre-clinical trials are being planned on a treatment for human parainfluenza virus discovered by the Institute for Glycomics. This treatment...
Gold Coast research has made a giant leap forward in understanding one of the most common causes of respiratory infections worldwide.
Researchers at Griffith University’s Institute for Glycomics have moved a step closer to identifying a treatment for the dreaded Human parainfluenza virus (hPIV).
Griffith's Institute for Glycomics has partnered with China Grand Pharma’s new Australian company Grand Medical Ltd to develop a drug to treat millions of people with respiratory illnesses.
The Institute for Glycomics has been awarded two National Health and Medical Research Council Investigator Grants.
Director and Head of Research for the Institute for Glycomics Professor Mark von Itzstein AO has been honoured with the Gold Coast Citizen of the Year award.
Griffith University research into fighting diseases of global impact are set to benefit from the latest National Health and Medical...
Griffith University's Institute for Glycomics has announced its 2016 research excellence awards.
Griffith University researchers have discovered a potential way to create an antimicrobial drug that would stop one of the world’s...